ARTICLE / CLIENT ALERT
New Illinois Protections Against Patient Medical Debt May Also Help Reduce Hospital Bad Debt
December 4, 2023
Read time: 11 min
Starting in mid-2024, Illinois hospitals will be required to take a much more active role in limiting consumers’ medical debt by screening all consenting uninsured patients for both public health insurance program coverage and hospital financial assistance eligibility as soon as reasonably practicable and before pursuing any collection action. Hospitals must track all uninsured patient declinations and failures to respond to all such offers in the uninsured patients’ medical records. Hospitals must also post on their public website the total number of uninsured patients who decline or fail to respond to such offers, along with the five most frequent reasons cited for doing so. Illinois hospitals will also be required to use their financial assistance policy to determine financial assistance eligibility for certain insured patients.
Beyond these screening requirements, Illinois hospitals must give impacted patients more time to act on their financial options before pursuing collection actions.
While these steps will surely reduce the medical debt burden of many individuals receiving care at Illinois hospitals, they present operational challenges for hospitals that must comply in order to avail themselves of any subsequent collections proceedings for unpaid amounts owed by patients. If given adequate resources and effort, hospitals could experience a reduction in bad debt by encouraging eligible uninsured patients to get health coverage.
The Protect Illinoisans from Unfair Medical Debt bill (the Bill), signed by Governor J.B. Pritzker on July 28, 2023, amends the Fair Patient Billing Act (the Billing Act), the Hospital Uninsured Patient Discount Act (the Discount Act) and the Community Benefits Act (the Benefits Act). The Bill, effective January 1, 2024, has four primary requirements for Illinois hospitals, all of which apply to services provided on or after June 29, 2024, and all of which must be taken before hospitals may lawfully pursue collection efforts:
- Hospitals must request consent from uninsured patients to screen for eligibility for public health insurance program coverage (e.g., Medicaid) and financial assistance eligibility as soon as reasonably practicable and before pursuing any collection action
- Hospitals must track all declinations or failures to respond in the uninsured patients’ medical records and the reasons for declining the same, the total number of which, along with the top five reasons, are to be publicly reported on each hospital’s website
- Hospitals must provide insured patients more opportunities to be considered for eligibility under a hospital’s financial assistance policy
- Beyond the screening obligations, Illinois hospitals must give uninsured patients and certain insured patients more time to act on their financial options before pursuing collection actions
UNINSURED PATIENTS: PUBLIC HEALTH INSURANCE PROGRAM AND HOSPITAL FINANCIAL ASSISTANCE ELIGIBILITY SCREENING OBLIGATIONS
As rewritten, the Billing Act will require hospitals to screen each uninsured patient who agrees to be screened for potential eligibility for public health insurance programs and for any financial assistance offered by a hospital. Patient consent to screening is a threshold decision that will implicate the subsequent next steps under each of the Billing Act, Discount Act and Benefits Act.
The Billing Act defines “screen” or “screening” as “a process whereby a hospital engages with a patient to review and assess the patient’s potential eligibility for any financial assistance offered by the hospital, public health insurance program, or other discounted care known to the hospital; informs the patient of the hospital’s assessment; documents in the patient’s record the circumstances of the screening; and assists with the application for hospital financial assistance.” The Billing Act requires that all such screening activities and all follow-ups be provided in compliance with the Illinois Language Assistance Services Act, which require interpreters to ensure adequate and speedy communication with patients and staff. Ensuring access to language assistance services is also required of hospitals to comply with Section 1557 of the Affordable Care Act, so hospitals would be well served to review their interpretation services agreements.
Uninsured Patients Who Decline To Be Screened
Hospitals must document when and why uninsured patients decline screening. Specifically, if a patient declines or fails to respond to the offer to be screened, the hospital must make note of this in the uninsured patient’s medical record, confirming the date and method by which the patient declined or failed to respond. Hospitals should also inquire as to the reason(s) why uninsured patients decline screening, because the changes to the Benefits Act require hospitals 1) to separately track the number of uninsured patients who decline to consent to the screening and those that fail to respond and 2) to report the five most frequent reasons that patients provide for declining to consent. These data points must be noted on the hospital’s website in the same location where the hospital posts its annual reports or on a prominent location on the homepage of the hospital’s website.
Uninsured Patients Who Consent To Be Screened
If an uninsured patient consents to be screened for eligibility for public health insurance programs and financial assistance offered by a hospital, then a hospital must complete the screening during registration or at the earliest reasonable moment if screening would cause an untenable delay of care to the patient.
If the screening indicates that the uninsured patient may be eligible for a public health insurance program, then the hospital must provide information to the uninsured patient about how to apply to said program(s), including but not limited to, referring the patient to:
- Healthcare navigators who can provide free and unbiased eligibility and enrollment assistance, including those at federally qualified health centers
- Local, state or federal government agencies
- Any other resources that Illinois recognizes as designed to assist uninsured individuals in obtaining health coverage
If an uninsured patient’s application for public health program insurance is approved, then the hospital must bill the relevant program and not pursue the patient for any aspect of the bill, other than applicable and required cost-sharing amounts. If the uninsured patient’s application for public health program insurance is denied, then the hospital must once again offer to screen the uninsured patient for eligibility under the hospital’s financial assistance policy, which restarts the clock for the patient to provide relevant information to the hospital in connection with the hospital’s financial assistance policy to reduce the amount the uninsured patient owes. Only after all of these steps have been taken may a hospital pursue collection actions against the uninsured patient.
INSURED PATIENTS: HOSPITAL FINANCIAL ASSISTANCE ELIGIBILITY SCREENING OBLIGATIONS
Under the new requirements of the Billing Act, hospitals must offer to screen insured patients for hospital financial assistance in the following four circumstances:
- If an insured patient specifically requests such screening
- If the hospital is contacted in response to a bill
- If the hospital learns of information that suggests an insured patient’s inability to pay
- If circumstances otherwise suggest the patient’s inability to pay
While the first circumstance is straightforward, the remaining three are trickier to operationalize. In the second scenario, every time a hospital’s billing department receives a call from an insured patient inquiring about a bill, the hospital should ask whether the individual would like to be screened for eligibility under the hospital’s financial assistance policy. In the third and fourth circumstances, the touchpoints whereby the hospital could learn of a patient’s financial hardship are far greater and varied. These requirements are onerous especially in the current environment, where the hospital workforce is already very challenged by the increased demands on their time. It is also unclear how the state will enforce compliance with these happenstances, as the enforcement provisions were not amended as part of the Bill. Until and unless further guidance is promulgated, we recommend a “best efforts” approach and training workforce on the Billing Act obligations.
COLLECTION ACTIONS
Uninsured Patients
Hospitals cannot pursue collections against uninsured patients without complying with the above-mentioned screening requirements. Also, the updates to the Billing Act and the Discount Act regarding hospital collection actions against uninsured patients create an extended process for uninsured patients to seek coverage and/or financial assistance and therefore prolong the period before a hospital can send the uninsured patient’s bills to collection agencies.
Starting in mid-2024, hospitals and their billing agents may not pursue collection actions against uninsured patients if the hospital 1) does not comply with the screening requirements for uninsured patients described above and 2) does not exhaust the discounts available to a patient under Section 10 of the Discount Act, which are not revised by the Bill but do have changes effective January 1, 2024, and are set forth in the Appendix below. If a patient does not submit relevant information that a hospital requests in connection with a completed screening, application for financial assistance or other payment plan documentation within 30 days, then a hospital must document this much, confirming the date of the screening and the 30-day timeline for responding to the hospital’s request(s). That said, hospitals must allow uninsured patients to apply for a discount at any point within 90 days of discharge, date of service, completion of the screening under the Billing Act or denial of an application for a public health insurance program—even if it occurs after the initial 30-day period noted above.
In addition, the Bill amended Section 15 of the Discount Act to acknowledge that if a hospital makes the availability of its discount programs contingent on an uninsured patient first applying for coverage under public health insurance programs, the hospital may nevertheless screen the patient for financial assistance eligibility if the patient declines to first apply for a public health insurance program out of concern for immigration-related consequences. In that case, the hospital may—but is not required—to direct those patients to a free, unbiased resource such as an Immigration Family Resource Program, to address the uninsured patient’s immigration-related concerns and assist in enrolling the patient in a public health insurance program. This reason should be cited in the patient’s medical record and included in the hospital’s tracking of reasons why patients decline to be screened for public health insurance program eligibility.
Insured Patients
Before referring an insured patient’s bill to collections, the Billing Act also requires hospitals to ensure compliance with these requirements and offer the implicated patient the opportunity to request a reasonable payment plan for the amount personally owned. Patients will have 90 days to request a payment plan after receiving an initial bill (up from 30 days), and if the patient does not agree to an offered reasonable payment plan within 90 days of the request (up from 30 days), the hospital may proceed with collection actions.
ENFORCEMENT
The Bill did not amend the enforcement provisions of the Billing Act, the Discount Act or the Benefits Act. Accordingly, under the Billing Act the Illinois Attorney General remains empowered to investigate complaints of noncompliance with the aforementioned screening obligations and to obtain injunctive relief or impose a corrective action plan as deemed appropriate. Furthermore, the Attorney General may seek civil monetary penalties of up to $500 for knowing violations involving a pattern or practice of not providing obligatory information to patients. If a hospital subsequently fails to engage in or refrain from certain activities, the penalty may grow to $1,000 per violation. Potential penalties are similar under the Discount Act for failing to make available discounts to eligible patients. The Benefits Act does not have an enforcement schema.
CONCLUSION
Hospital compliance with these new obligations will require interdepartmental coordination and open communication so that patients are availed of these opportunities, hospitals bring down their bad debt caused by uninsured individuals, and hospitals can pursue collections for outstanding patient obligations.
Given the six-month delay between the Bill’s effective date and the true date by which the hospital obligations under the Bill become legal requirements, Illinois hospitals have time to operationalize their compliance approach. Existing legal requirements—such as the Affordable Care Act requirement to provide language assistance services and the No Surprises Act requirement to provide uninsured and self-pay patients who are scheduling services with an estimate of their expected charges—provide some existing infrastructure for hospitals to build out their compliance workplans.
For more information or for assistance regarding the Bill, please contact one of the authors.

West Coast Forum 2023 | Key Takeaways
ARTICLE
West Coast Forum 2023 | Key Takeaways
November 1 – 2, 2023
Read time: 8 min
McDermott’s Private Client Practice led interactive discussions on a broad range of topics pertinent to ultra-high-net-worth families, their family office representatives and other advisors at our Private Client West Coast Forum 2023 on November 1–2, 2023. Highlights and key takeaways from the sessions are summarized below.
THE HERE & NOW: CURRENT DEVELOPMENTS IMPACTING ULTRA-HIGH-NET-WORTH FAMILIES & FAMILY OFFICES
Partners Katy Crafton Fluet and Nicole M. Pearl highlighted recent developments on a wide range of legal issues potentially relevant for family offices.
- Estate tax deduction regulations: Newly proposed regulations under Internal Revenue Code (IRC) Section 2053 offer guidance on estate tax deductions relating to future expenses and claims, Graegin loan interest and amount paid pursuant to personal guaranty.
- Valuing cryptocurrency: Chief Counsel Advice Memorandum 202302012 confirmed that cryptocurrency is not a security, and a qualified appraisal is required to claim a charitable deduction under IRC Section 170. Similarly, Chief Counsel Advice Memorandum 202302011 confirmed that cryptocurrency is not a security eligible for a loss deduction under IRC Section 165(g).
- CA directed trust statute: California recently enacted a directed trust statute (Cal. Prob. Code Section 16600), which will go into effect on January 1, 2024.
- No basis step up for irrevocable grantor trusts: Rev. Rul. 2023-2 confirmed that assets held in an irrevocable grantor trust at the time of a decedent’s death which are not included in the decedent’s gross estate will not receive a basis step-up by reason of the decedent’s death.
- Merger impact on stock valuation: In Baty v. Commissioner, the government conceded that merger negotiations should not be considered in valuing contribution of publicly traded stock to a grantor-retained annuity trust.
- Defined value clauses: The Tax Court’s decision in Sorenson v. Commissioner offers valuable lessons in the planning and administration of transfers involving defined-value clauses.
- Greenbook proposals: Various proposals included in the US Department of the Treasury’s 2024 “Greenbook,” while unlikely to become law prior to the 2024 election, indicate areas of interest to the current administration. Notable proposals address valuation discounts, limitations on the benefits of generation-skipping transfer tax exemption, restrictions on certain annuity trusts and distributions from private foundations to donor-advised funds (DAFs).
SUCCESSION – THE SEQUEL: DEALING WITH THE AFTERMATH OF DYSFUNCTIONAL FAMILY RELATIONSHIPS
During this session, Partners Robert Barton and Laurelle M. Gutierrez addressed how family dynamics, pre-death conflicts and post-death conflicts lead to legal battles that may be mitigated and/or avoided by communication in the planning phase. The panelists identified a variety of situations that lend themselves to legal disputes in order to assist clients with their estate planning and end-of-life considerations.
- Family dynamics: Disputes often arise from dysfunctional family relationships, miscommunications, cognitive or physical deterioration of a relative, geographic isolation or abandonment, personality issues, miscommunications and marital disputes.
- Pre-death conflicts: Undue influence is a common type of litigation/controversy that arises when someone in a position of power or authority coerces or pressures an individual to make or change a will/trust. Elder abuse is another common type of litigation/controversy, usually arising from the physical, mental or financial abuse by a care custodian on an elderly individual. Importantly, this claim does not require malicious intent. Standing by a beneficiary to contest a will/trust arises as soon as the trustor becomes incompetent, and the trustee now is required to inform the beneficiaries of the incompetency and to provide a copy of the will/trust to the beneficiaries.
- Post-death conflicts: Will/trust contests often occur after death by upset family members with unmet expectations. Importantly, “no contest” causes don’t always save the plan. Intentional interference with expected inheritance is a tort claim that can be brought if a will or trust contest cannot be successfully brought. Breach of fiduciary duty is a claim that can be brought against a trustee for failure to conform with multiple duties including, but not limited to, loyalty, impartiality and disclosure.
- Avoiding the battles: Communicate your estate plans, assets and trusts every year, if not more frequently, to your loved ones and intended beneficiaries to avoid potential legal battles. It helps to address the equal, not equitable, division of assets and control. Tools to assist avoiding legal battles include negotiated estate plans and the use of entities that manage inherited property independently of family, such as corporate fiduciaries or family offices/private trust companies.
LABOR LAW & PRIVACY: TOP FIVE STRATEGIES FOR MANAGING WORKFORCE RISK
Employment Partners Christopher A. Braham and Christopher Foster discussed navigating employment law and privacy issues for family offices. They explored proper worker classification, structuring employing entities and relationships to mitigate and control risk, strategies to ensure worker confidentiality, proactive communication, and conflict resolution tools and techniques.
- Classifying workers: When classifying workers as employees or independent contractors, the best practice is to generally presume workers should be employees with limited exceptions. This helps to minimize the risk for potential liability, penalties, audits and negative unwanted publicity from a misclassification claim.
- Liability exposure: To manage and reduce exposure for liability, it is important to clearly designate and structure the employing entity and relationships to service recipients.
- Applicant/employee evaluation: During evaluation of an applicant/employee, best practices include checking references, conducting background checks, and ensuring compliance with federal and state background check and antidiscrimination laws.
- Confidentiality: Confidentiality is critical from hire to separation. Develop a tailored strategy for confidentiality agreements, policies and practices and managing separations.
- Managing claims: To manage employees effectively and reduce the likelihood of claims, and to reserve defense in the event of a claim, it is critical to provide (and document) candid performance assessments.
- Resolving conflict: Strongly consider use of arbitration and dispute resolution agreements and terms to help resolve conflicts and protect confidentiality.
MEGA DONORS: PLANNING FOR MULTIMILLION DOLLAR CHARITABLE GIFTS
During this session, Partners Elizabeth R. Glasgow and Kathryn C. Gose discussed recent trends in philanthropy, highlighting one high-profile donor’s method of “trust-based philanthropy.” The panelists also discussed their guiding principle in advising on charitable giving: Clients should apply the same scrutiny and attention to detail brought to for-profit transactions to their philanthropic gifts.
- Donor due diligence: Public charities remain an attractive option for mega gifts, but large public charities are increasingly subjecting potential donors to rigorous vetting processes before accepting large gifts.
- DAF caution: DAFs remain a flexible charitable vehicle for gifts; yet, as the 2021 Fairbairn case demonstrates, DAF flexibility has limits. DAF donors must be prepared to relinquish ultimate control of the donated assets.
- Gift agreements: Gift agreements should be as carefully and thoroughly negotiated as any for-profit transaction. Mega donors wanting to make restricted gifts should carefully consider the scope of the restriction, benchmarks, contingencies and enforcement mechanisms.
- Remember, remember the disqualified person: The identity of “disqualified persons” can change over time. When funding private foundations and other vehicles potentially subject to excise taxes, donors need to keep track of ongoing risks. Remain on guard!
- Gifting with business interests: Charitable vehicles face practical and tax obstacles when holding business interests. Planning for the donation of a business interest should include planning for its disposition by the charity.
CTA, FINCEN & FBARS, OH MY!
Partners Daniel J. Bell and Chris Nason discussed the existing foreign reporting requirements and the newly passed Corporate Transparency Act. They reviewed best practices on reporting, ongoing compliance, and consequences for failure to file and disclosure.
- Foreign reporting requirements: There are numerous existing reporting requirements applicable to individuals and entities which own foreign assets, receive gifts from foreign people or have interactions with foreign trusts. While some reporting obligations can be easily determined, there are some that require in-depth analysis. Maintaining awareness of reporting triggers and thresholds is important in helping individuals and entities stay apprised of changes that could subject them to reporting from year to year.
- Information disclosure: The Corporate Transparency Act imposes a new reporting requirement effective January 1, 2024. This reporting requires disclosure of information about entities organized or doing business in the US, their beneficial owners and controlling persons. Reporting will be due as soon as within 90 days of entity formation for entities created in 2024. The system and mechanism for e-filing are still under development.
- Reducing exposure: Individuals and entities should take the time now to understand new or existing reporting requirements. Doing so will help ensure that reporting is completed in a timely manner.

Mobility@McDermott: Monthly Update (11/2023)
ARTICLE / CLIENT ALERT
Mobility@McDermott: Monthly Update (11/2023)
December 4
Read time: 9 min
1. Proposal for EU directive for right to repair no longer covering motor vehicles
The European Parliament’s Internal Market and Consumer Protection Committee has voted on a draft report on the proposed EU directive which is intended to promote a “right to repair” for consumers. Unlike the original draft proposed by MEP René Repasi, the final version agreed by the committee no longer covers motor vehicles and trailers. Industry associations had previously warned that applying the directive to motor vehicles would not be appropriate.
The committee urged EU member states to remove software restrictions and other barriers to repair by independent workshops.
Relevant for: Manufacturers.
Further details here (available in English)
2. German parliament introduces restrictions on payment protection insurances
On 17 November 2023, the German parliament (Bundestag) passed the much-anticipated Financing for the Future Act (Zukunftsfinanzierungsgesetz). While the legislation focuses on promoting start-ups and improving access to capital markets, it also included new restrictions on payment protection insurance (Restschuldversicherungen) that are likely to have a significant impact on banks and finance providers in Germany.
Under the new legislation, lenders cannot require consumers to take out a payment protection insurance when granting a general consumer loan. Equally relevant in practice will be the requirement that one week must elapse between the conclusion of a general consumer loan and the conclusion of a payment protection insurance. If less time has elapsed, the payment protection insurance contract will be null and void. Some associations have stated that the introduction of the cooling-off period is tantamount to a de facto ban on payment protection insurance, which is an important source of income for many consumer banks. In addition, they argue that such mechanism contradicts Directive (EU) 2023/2225 of the European Parliament and of the Council of 18 October 2023 on credit agreements for consumers.
Relevant for: Banks, finance providers, insurers.
Further details here (available only in German)
3. German Federal Court of Justice finds that manufacturer is liable for emission standard violation
In a ruling issued on 27 November 2023, Germany’s highest civil court, the Federal Court of Justice (Bundesgerichtshof, “BGH”) reaffirmed its case law that an OEM can be liable for negligent violations of emissions standards caused by a vehicle’s engine, even if the engine is manufactured by a third party. In this case, the plaintiff had purchased an RV from a third party and then sued the RV’s manufacturer which in turn had purchased the RV’s engine from a cooperation partner.
The court’s decision is in line with other BGH rulings from a few months ago, when the BGH had to adjust its legal assessment of cases in connection with the so-called “diesel scandal” involving manipulated engine emission systems (BGH ruling VIa ZR 335/21 of 26 June 2023, BGH ruling III ZR 267/20 of 20 July 2023) following a court decision by the European Court of Justice (“ECJ”). Previously, the BGH had required proof of intentional wrongdoing by an OEM in order to find it liable. The ECJ then ruled that by issuing a certificate of conformity, often referred to as a CoC document, for an individual vehicle, the manufacturer confirms to the vehicle owner that the vehicle complies with all of the relevant European regulations (ECJ ruling C-100/21 of 21 March 2023). As a result, only negligent behaviour on the part of the OEM needs to be proven in order to establish liability.
According to the BGH, the legal possibility of a restriction of the use of a vehicle, e.g. caused by the implementation of an illegal emission system, is sufficient to give rise to a claim for damages, as it affects the monetary value that represents the availability of the motor vehicle at all times.
Relevant for: Manufacturers.
Further details here (available only in German)
4. EU parliament adopts EU Data Act
On 9 November 2023, the European Parliament passed the Data Act. As previously reported in our Monthly Update 06/2023, one of the main purposes of the Data Act is to create a framework that allows users of “connected devices” to gain access to data generated by their use including visual or audio recordings. Connected devices also cover a wide range of IoT devices, from health devices and virtual assistants to connected vehicles.
The EU wants to give both individuals and businesses more control over their data through a strengthened right to data portability, which allows data to be easily copied and transferred between different services. According to the EU, aftermarket service providers, for example, will be able to improve and innovate their services and compete on a level playing field with similar services offered by manufacturers. This could lead to users of connected products being able to choose a more affordable repair and maintenance provider.
The Data Act still needs to be confirmed by the EU member states before it can take effect, but this is expected to be a formality.
Relevant for: Manufacturers, service providers.
Further details here
5. Non-compete restrictions impact potential competition and can infringe antitrust rules
On 26 October 2023, the European Court of Justice (“ECJ”) issued a preliminary ruling on a cooperation agreement between a Portuguese energy supplier and a supermarket chain. Under the cooperation, customers who were members of the supermarket chain’s loyalty program were eligible for discounted energy supply contracts. The parties also entered into a non-compete agreement for the duration of the cooperation and for one year thereafter.
The Portuguese competition authority had imposed a fine of EUR 34.5 million on the parties having found that the non-compete infringed antitrust rules as it amounted to market sharing.
Although the parties’ products and markets were very different, the ECJ confirmed the authorities’ interpretation of potential competition and held that the need to agree a non-compete in itself provides a strong indication that there is a real and concrete possibility (as opposed to hypothetical) that the parties may potentially compete. Alongside the restriction, the ECJ suggested that subjective evidence, the market environment as well as any activities of a wider group are particularly relevant in assessing whether a company would realistically (re)enter the market. Importantly, the fact that there were no preparatory steps undertaken should not play into the assessment, i.e. a restriction that purely restricts potential competition is suffi-cient to infringe antitrust rules.
Helpfully, the ECJ highlighted that the non-compete in question may be considered to exceed the scope of the cooperation and would therefore be unlikely to constitute an ancillary restraint (which permits non-compete restrictions if necessary and proportionate to the objectives sought under a neutral cooperation).
Relevant for: All business with cooperation partners in the mobility sector.
Further details here
6. The German competition authority has new powers to enforce the outcome of a market sector investigation
On 7 November 2023, the 11th amendment to the German antitrust laws entered into force.
The amendment provides the German regulator, the Federal Cartel Office (“FCO”), with more power to enforce competition and make outcomes “fairer”:
1. following a sector investigation, the FCO will now be able to (a) require companies to adopt measures to remedy a “distortion” of competition, even when the distortion results from conduct that complies with all laws, and (b) force a company active in the sector to notify all transactions where the acquirer generated EUR 50 million and the target EUR 1 million in Germany;
2. the FCO can now presume that a company benefitted from anti-competitive conduct and require the company to disgorge at least 1 % of turnover as part of the FCO’s decision on such conduct; and
3. the FCO will be able to use its investigatory powers (including the right to conduct dawn raids) to assist the Commission in enforce the EU Digital Markets Act (DMA).
In addition, the Amendment also opens up the possibility for private enforcement under the DMA. Individuals will in future be able to turn to the German courts to bring actions against “gatekeepers” that infringe the DMA.
Relevant for: All companies in the mobility sector (and beyond).
7. German court finds price adjustment clauses used by streaming providers to be invalid
The Court of Appeal in Berlin (Kammergericht Berlin) has rejected clauses used by two streaming providers in their general terms and conditions that gave them a unilateral right to raise prices.
The terms and conditions allowed the companies to increase prices under certain conditions without the consent of their customers, for example if the costs of providing their service increased. However, the terms and conditions did not provide that subscription prices may also decrease. As the rulings can still be appealed, they are not yet legally binding.
The price adjustment mechanisms of several streaming providers have been found invalid in recent months. Some of them have now changed their policy and now require explicit consent from their customers in case of price increases.
Relevant for: Mobility providers.
Further details here (available only in German)
8. German Ministry launches public consultation on modernisation of competition law
On the 6th November, the German Federal Ministry for Economics and Climate Action (Bundeswirtschaftsministerium) launched a public consultation on modernizing competition law. Companies, organizations, associations and citizens have until 4 December 2023 to submit ideas on how the ministry could improve the regulatory framework.
The aim is to further develop the competition policy agenda for the second half of the legislative period in Germany. Key issues are, amongst others:
1. Merger control. Whether all “relevant” transactions are currently caught by the merger control regime, and if so, whether the substantive assessment reflects modern business practices (particularly digital interactions). Similarly, in relation to merger control, the Ministry wants feedback on the exception for ministerial approval.
2. Sustainability. The Ministry wants to better understand what tools or guidance should be provided to allow companies to better cooperate on and facilitate sustainable goals. In particular, what factors should be considered to exempt a restrictive agreement on the basis of efficiency gains.
3. Private enforcement. The Ministry would like to understand how to streamline private antitrust damage claims and make them more effective.
Relevant for: All companies in the mobility sector (and beyond).
Further details here (available only in German)

OIG Issues Limited but Favorable Advisory Opinion on Proposed Bonuses to Physician Employees Paid From ASC Profits
ARTICLE / CLIENT ALERT
OIG Issues Limited but Favorable Advisory Opinion on Proposed Bonuses to Physician Employees Paid From ASC Profits
December 1, 2023
Read time: 6 min
The US Department of Health and Human Services Office of Inspector General (OIG) recently issued Advisory Opinion (AO) 23-07, analyzing a proposed arrangement to pay physicians in a multi-specialty group practice bonuses that tie to profits from the practice’s ambulatory surgery centers (ASCs). Based on the specific facts and circumstances of the proposed arrangement, OIG reached a favorable conclusion, finding that the proposed arrangement would qualify for protection under the broad safe harbor for employee compensation under the federal Anti-Kickback Statute (AKS). While AO 23-07 is a helpful confirmation of the breadth of the employee compensation exception and safe harbor, we note this opinion is narrowly focused on and limited to the specific facts presented—namely, that a physician practice’s ASCs, operating under the practice’s own tax identification number, would be considered part of the practice and could be counted when using practice profits to compensate practice physicians.
THE PROPOSED ARRANGEMENT
The AO was requested by a multi-specialty physician practice that furnishes services reimbursable by federal healthcare programs through 11 employed physicians. The practice stated that it planned to operate two Medicare-certified ASCs, in which certain of its physicians perform outpatient surgical procedures, under its own tax identification number (i.e., not as a subsidiary or separate corporate entity). These ASC proceduralist physicians are paid W-2 employment compensation by the practice for the services they provide on the practice’s behalf and would all qualify as bona fide employees.
The practice proposed to compensate its employee physicians who perform outpatient procedures at the ASCs under a new bonus compensation arrangement. Under the new arrangement, each physician, in addition to their base compensation, would receive a quarterly bonus of 30% of the practice’s net profits from the ASC facility fee collections attributable to that physician’s procedures performed at the ASC that quarter.
OIG ANALYSIS
OIG noted that typically, tying physician compensation to profits generated from services to patients referred by the compensated physician are suspect under the AKS. However, OIG concluded that the proposed arrangement fell within the statutory exception and regulatory safe harbor for compensation to bona fide employees.
The AKS statutory exception for employees protects “any amount paid by an employer to an employee (who has a bona fide employment relationship with such employer) for employment in the provision of covered items or services” (42 U.S.C. § 1320a-7b(b)(3)(B)). The regulatory safe harbor similarly carves out “any amount paid by an employer to an employee, who has a bona fide employment relationship with the employer, for employment in the furnishing of any item or service for which payment may be made,” under federal healthcare programs from the definition of “remuneration” prohibited by the AKS (42 C.F.R. § 1001.952(i)).
OIG determined that the statutory exception and regulatory safe harbor for employees applied to the bonus compensation because:
- The practice certified that the physician employees would be bona fide employees of the practice (as defined in 26 U.S.C. § 3121(d)(2))
- The bonus would constitute compensation to a bona fide employee for furnishing a service reimbursable by a federal healthcare program
OIG notes that similar bonus compensation arrangements, such as those to independent contractors or those in which the physicians receiving the bonuses were owners of the ACSs and received the bonuses in the form of ownership distributions, may raise fraud and abuse concerns under the AKS.
KEY TAKEAWAYS
The employee exception and safe harbor offer flexibility to structure compensation programs to improve alignment between healthcare providers and their physician employees. It is helpful for OIG to confirm the significant breadth of the employment exception and safe harbor. OIG has stated for many years, including in the first safe harbors, that employees may be paid for generating business for their employer. However, AO 23-07 is more interesting for what it does not say.
First, the requestor stated that it would not furnish any designated health services (DHS) and that the proposed arrangement would not implicate the physician self-referral law. This is a curious certification, as most physician practices furnish DHS. Perhaps the requestor meant that there was no DHS in the ASC arrangement, which would make sense because ASC services are not DHS. The AO is unclear on this issue. Even if the requestor furnished DHS at the practice, it is not obvious how that would change the employment bonus analysis. Since ASC services are not DHS, paying employed physicians a percentage of ASC facility profits would not be a payment for DHS.
Second, the requestor appears to have been restructuring its ASC as part of the request, but did not make that restructuring part of the request. Specifically, the requestor stated it “plans to operate the two ASCs as corporate divisions of Requestor (i.e., as divisions within the same legal entity as Requestor and not as subsidiaries of Requestor)” and the requestor “has not asked [OIG] to opine on, and [OIG] express[es] no opinion regarding, remuneration related to any corporate restructuring of requestor or any ownership distributions provided by requestor.” (Emphasis added). As a result of the requestor’s framing of the request, it is not clear what the ASC ownership structure was prior to the request or why or how requestor made the ownership change. The factual situation of an ASC being a “division” of a practice is relatively uncommon. Analytically, there does not appear to be much of a difference between an ASC as a division of a practice and an ASC as a wholly owned subsidiary of a practice, which is a common structure, but this AO addresses the former. Similarly, in the health system and group practice contexts, employers may want to encourage their employed physicians to perform cases at affiliated ASCs or hospitals, which are not the entities that actually employ the physicians. The potential regulatory risk associated with an employer’s compensation to its employees based on the use of affiliated entities is a fact-specific analysis.
Ultimately AO 23-07 leaves more questions unanswered than it answers. However, it is beneficial that AO 23-07 confirms the broad protection that the employee exception and safe harbor provides to compensation arrangements that fall within its scope.
Finally, we note that OIG’s analysis only addresses issues under the federal AKS. OIG does not express any opinion regarding the proposed arrangement’s compliance with any state law or the issues such an arrangement would pose under other potentially applicable federal law, such as the physician self-referral law. Before entering into a similar arrangement or considering the potential risk profile of practice-owned or affiliated ASCs, entities should consult legal counsel for an analysis under both federal and applicable state law.

Delaware Court of Chancery Upholds Identity-Based Voting Within Single Class of Stock
ARTICLE / CLIENT ALERT
Delaware Court of Chancery Upholds Identity-Based Voting Within Single Class of Stock
December 1, 2023
Read time: 5 min
A recent opinion from the Delaware Court of Chancery reaffirmed a Delaware corporation’s ability to create a class of stock with voting power that is based on a formula in the certificate of incorporation (Charter) or on facts ascertainable outside the Charter (including the identity of the holder), even if it generates different results for different holders, so long as it applies across all shares of such class. Colon v. Bumble, Inc., No. 2022-0824-JTL, 2023 WL 5920100 (Del. Ch. Sept. 12, 2023). This case serves as a reminder of the flexibility afforded to Delaware corporations in allocating voting power amongst stockholders, even stockholders within the same class of stock.
FACTS AND HOLDING
Bumble, Inc., a Delaware corporation, went public with a Charter using a governance structure that provided superior voting rights to the “Principal Stockholders”—defined as the parties to a publicly disclosed stockholders’ agreement. Those parties are Bumble founder Whitney Wolfe Herd and Bumble’s primary investor, Blackstone, Inc. The Charter authorizes two classes of common stock: Class A stock and Class B stock. Each share of Class A stock carries one vote per share unless that share is held by a Principal Stockholder in which case it carries 10 votes per share and economic rights in Bumble. The Class B stock, the only two shares of which were issued to Herd and Blackstone, carries one vote per share unless that share is held by a Principal Stockholder in which case it carries 10 votes per share and no economic rights in Bumble. As a result, Herd and Blackstone hold 92.2% of the outstanding voting power in Bumble.
The plaintiff asserted that the Charter created an identity-based capital structure that granted disparate voting rights among holders of the same class of stock and violated (i) Section 212 of the General Corporation Law of the State of Delaware (DGCL) because Section 212 ties a stock’s attributes to the stock itself—not the holder of the stock—and, therefore, special voting power may not be granted to individuals as a personal right irrespective of stock ownership, and (ii) Section 151 of the DGCL because it requires that each share of a class or series of stock have identical rights. The parties filed cross-motions for summary judgment.
The Court explained that a Charter can modify, enhance, limit or eliminate some of the default rights under the DGCL and voting rights of stock are one of those rights. Although Section 212(a) provides a default right of one vote per share, such right can be altered in a Charter. Furthermore, “[n]othing in Section 102(a)(4), 151(a), or 212(a) requires that the charter frame the voting power appurtenant to a share in terms of a specific number of votes per share. Not only that, but Section 151(a) permits special attributes, including voting rights, to depend on facts ascertainable outside of the certificate of incorporation.” Section 151(a) defines “facts” broadly by providing a nonexclusive list of what constitutes as “facts,” including “the occurrence of any event, including a determination or action by any person or body, including the corporation.”
The Court discussed long-standing Delaware precedent holding Charter provisions that allocated voting power using a formula or procedure (i.e., tenured voting rights based on how long the shares were owned, scaled voting rights depending on the number of shares owned and per capital voting rights regardless of the number of shares owned) as valid under the DGCL. Based on this precedent and the DGCL, the Court held that the challenged provisions were valid since, as required by Sections 102(a)(4) and 151(a), the Charter provides for a formula that applies to all shares of a class and such formula specifies how voting power is allocated. The Charter may rely on facts ascertainable outside of it, which in this case was the identity of the holder of shares (i.e., the Principal Stockholders). The Court also held (consistent with precedent) that a formula need not result in the same outcome for each share of stock so long as the formula is applied identically across all shares. Therefore, the Court granted Bumble’s motion for summary judgment. Importantly, the Court noted that while the challenged provisions were valid under the DGCL, the Court was not ruling on whether identity-based voting structures would always be equitable.
TAKEAWAYS
- This case is a helpful reminder that a Delaware corporation can provide for different rights among shares of the same class or series in its Charter, including different voting rights, as long as the method for determining such rights is applied consistently among such shares.
- The powers and rights of any class or series of stock can be made dependent on facts ascertainable outside the Charter, including agreements or documents, the occurrence or non-occurrence of an event, or the determination or action of any person.
- Although a provision contained in a Charter (like the provisions in this case) will be found to comply with the DGCL, such a provision or its application can still be challenged as being inequitable since corporate action under Delaware law is always twice tested—once for legal compliance and again for equity.

The Corporate Transparency Act: FinCEN Extends Filing Deadline From 30 to 90 Days For Reporting Companies Created or Registered in 2024
ARTICLE / CLIENT ALERT
The Corporate Transparency Act: FinCEN Extends Filing Deadline From 30 to 90 Days For Reporting Companies Created or Registered in 2024
December 1, 2023
Read time: 4 min
On Jan. 1, 2024, the beneficial ownership information reporting rule (“BOI Rule”)[1] implementing the Corporate Transparency Act (“CTA”)[2] will go into effect, requiring each domestic and foreign reporting company to file a beneficial ownership information report (“BOI Report”) with the US Department of the Treasury’s Financial Crimes Enforcement Network (“FinCEN”). Under the BOI Rule, entities created or registered on or after Jan. 1, 2024 had 30 days to file a BOI Report. Yesterday, FinCEN amended the BOI Rule by temporarily extending the filing deadline to 90 days for reporting companies created or registered to do business in the US on or after Jan. 1, 2024 and before Jan. 1, 2025.[3]
The extension provides entities that are “Reporting Companies”[4] created or registered in 2024 with additional time to understand the BOI Rule reporting obligations and collect the information necessary to file a BOI Report. As a result of this amendment, a reporting company created or registered in calendar year 2024 must file their initial BOI Report with FinCEN within 90 calendar days of the earlier of: (1) the date it receives actual notice that its creation or registration is effective; or (2) the date a secretary of state, or a similar office, first provides public notice that the reporting company was created or registered to do business. Beginning Jan. 1, 2025 the filing deadline for a reporting company’s initial BOI Report will revert back to 30 days after receiving notice of formation or registration.
Importantly, in this amendment, FinCEN did not extend the deadline for:
- reporting companies created or registered before 1, 2024. These reporting companies must file their initial BOI Report with FinCEN by Jan. 1, 2025.
- updating or correcting BOI Reports. Reporting companies must still submit updated or corrected BOI Reports within 30 days of (i) any change to the information previously reported in the BOI Report regarding the reporting company or its beneficial owners; or (ii) becoming aware (or having reason to know) of an inaccuracy regarding the information previously reported in the BOI Report.
Authored by Michael S. Didiuk, Melissa G.R. Goldstein, Betty Santangelo, Jessica Romano and Kyle B. Hendrix.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
[1] 31 C.F.R. § 1010.380; Final Rule, Beneficial Ownership Information Reporting Requirements, 87 Fed. Reg. 59498 (Sept. 30, 2022), available here.
[2] The CTA was enacted in January 2021 as part of the National Defense Authorization Act for Fiscal Year 2021 (“NDAA”) (CTA §§ 6401–03), available here. For more information regarding the CTA and the Anti-Money Laundering Act of 2020, both enacted as part of the NDAA, please see our prior Alert ”Passage of Anti-Money Laundering Act of 2020 Includes Comprehensive BSA/AML Reform Measures,” available here.
[3] FinCEN, Final Rule, Beneficial Ownership Information Reporting Deadline Extension for Reporting Companies Created or Registered in 2024, 88 Fed. Reg. 83499 (Nov. 30, 2023), available here.
[4] For a discussion of what a reporting company is, please see our prior client Alerts: (1) “FinCEN Issues Final Rule Requiring Reporting of Beneficial Ownership Information,” available here; (2) “The Corporate Transparency Act: Key Considerations for Compliance With the Beneficial Ownership Reporting Rule,” available here and (3) “The Corporate Transparency Act: The Private Funds Guide to Compliance With the Beneficial Ownership Reporting Rule,” available here.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. © 2023 Schulte Roth & Zabel LLP. All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

Final Comment Period Anticipated Next Week for Emergency Regulations on California’s New Healthcare Transaction Notice Law
ARTICLE / CLIENT ALERT
Final Comment Period Anticipated Next Week for Emergency Regulations on California’s New Healthcare Transaction Notice Law
November 30, 2023
Read time: 5 min
On November 28, 2023, California’s Office of Health Care Affordability (OHCA) published a notification of proposed emergency regulatory action indicating that OHCA is planning to submit the proposed regulations to the Office of Administrative Law (OAL) in five business days, on or around December 5, 2023.
These proposed regulations concern the 90-day pre-closing notice requirement and cost and market impact review (CMIR) process for California transactions closing on or after April 1, 2024. We described and analyzed these issues in our prior On the Subject articles, “California Publishes Draft Regulations on Filing Requirement for Healthcare Entity Transactions” and “OHCA Updates Draft Regulations on California Healthcare Transaction Notice Requirement.”
PROPOSED CHANGES
There have been two prior comment periods during the drafting process for the regulations at hand. For a detailed analysis of changes in the regulations over time, read our prior On the Subject articles mentioned above. In the proposed final regulation text, OHCA has made fewer changes compared to the last round of revisions. The most significant changes found in the proposed emergency regulations include the following:
- A material change transaction previously included transactions involving the sale or disposition of 25% or more of the total California assets of any healthcare entity in the transaction. This was changed to the sale or disposition of 25% or more of the assets of the “submitter,” i.e., the healthcare entity or entities required to submit the notice to OHCA, which could include the buyer, seller or both, depending on the specific circumstances of the transaction.
- The definition of a material change transaction no longer includes the following (but note that a transaction may still be considered a material change if it falls under the other categories in the regulations):
- A transaction involving a healthcare entity joining, merging or affiliating with another healthcare entity, affiliation, partnership, joint venture or parent corporation related to the provision of healthcare services where any healthcare entity has at least $10 million in annual California-derived revenue.
- A transaction that changes the form of ownership of a healthcare entity that is a party to the transaction, including but not limited to a change from physician-owned to private equity-owned or from publicly held to privately held forms of ownership.
- For determining whether the healthcare entities meet the revenue thresholds, the regulations clarify that such revenue is determined on a cash basis, rather than an accrual basis.
- Two of the timelines for OHCA’s review (the timeline for OHCA’s release of the final CMIR report following the public comment period and OHCA’s ability to extend the 90-day period for preparing the preliminary CMIR report) have decreased by 15 days each. However, OHCA still retains the ability to toll such review periods for various reasons, such as when it is awaiting further information or when other governmental agencies are reviewing the transactions.
- The prior draft regulations indicated that OHCA will determine whether it will conduct a CMIR within 60 days of receipt of the notice. The new language indicates that OHCA will inform the submitter of its decision not to conduct a CMIR within 45 days of receipt of the notice but will still inform the submitter of its decision to conduct a CMIR within 60 days of receipt of the notice. Thus, if the submitter has not heard back from OHCA within 45 days, there may be a strong likelihood that OHCA has determined to conduct the CMIR.
COMMENT SUBMISSION
Following the submission of the proposed emergency regulatory action to OAL, stakeholders will have five calendar days to submit comments on the proposed emergency regulations.
Assuming that OAL receives the proposed emergency regulatory action on December 5, 2023, comments will be due on December 10, 2023. Comments should be submitted simultaneously to OHCA and OAL, according to the instructions provided in the notification of proposed emergency regulatory action.
Stakeholders may submit comments on the text of the proposed emergency regulations and/or OHCA’s finding of emergency, which contains OHCA’s justification for utilizing the emergency rulemaking process. OAL will have 10 calendar days following OHCA’s submission to make a decision on the proposed emergency regulatory action and is likely to do so on or around December 15, 2023. If the regulations are approved, OAL will file the regulations with the California Secretary of State, and they will be effective for five years. Of note, during the period in which the emergency regulations are effective, OHCA will proceed with a regular rulemaking action, including an additional public comment period.
NEXT STEPS
Stakeholders who wish to submit additional comments should prepare such comments for submission on or before December 10, 2023. This date is subject to change, depending on when OHCA actually submits the proposed emergency regulatory action to OAL. The public may monitor the OAL website to determine the precise date OAL receives the emergency regulations.
As we described in our prior articles, determining whether a notice is required is a highly technical but important analysis, as the CMIR process has the potential to delay closing by several months. California healthcare entities entering into transactions closing on or after April 1, 2024, should factor these potential delays into the overall transaction timeline and should consider the additional costs associated with preparing the notice and reimbursing OHCA for its costs of review.

Recent Tax Court Opinion May Alter Limited Partners’ Self-Employment Tax Liability
ARTICLE / CLIENT ALERT
Recent Tax Court Opinion May Alter Limited Partners’ Self-Employment Tax Liability
November 30, 2023
Read time: 4 min
On Nov. 28, 2023, the United States Tax Court issued an opinion with respect to competing motions for summary judgment in the case of Soroban Capital Partners LP v. Commissioner [1], addressing the US federal self-employment tax liability of limited partners in a state law limited partnership. The Tax Court denied Soroban’s motion for summary judgment, holding that a functional analysis test, similar to the test outlined in Renkemeyer [2] and subsequent cases, should be applied when determining whether the limited partner exception under section 1402(a)(13) [3] applies to limited partners in state law limited partnerships. The Tax Court opined that “the limited partner exception does not apply to a partner who is limited in name only” and that Congress “intended for the phrase ‘limited partners, as such’ used in section 1402(a)(13) to refer to passive investors.” Factual determinations regarding the limited partners’ roles and activities will be made in further proceedings.
In general, section 1401 imposes a tax on an individual’s self-employment income. However, section 1402(a)(13) excludes from income subject to self-employment tax “the distributive share of any item of income or loss of a limited partner, as such, other than guaranteed payments described in section 707(c) to that partner for services actually rendered to or on behalf of the partnership to the extent that those payments are established to be in the nature of remuneration for those services.” Historically, many investment managers have formed management entities as limited partnerships and their limited partners have taken the position that their distributive shares of income from those limited partnerships are not subject to the 3.8 percent Medicare portion of self-employment tax in accordance with section 1402(a)(13), even if such limited partners actively participate in the activities of the investment manager.
If sustained, the Tax Court opinion establishes as a matter of law that a limited partner that actively participates in the activities of a state law limited partnership is not eligible for the exclusion under section 1402(a)(13) solely by virtue of being a limited partner. We will continue to monitor developments in this and similar cases (including a final court decision in this case and any potential appeal) and industry practice. Based on these developments, investment managers that are formed as limited partnerships and their partners are encouraged to review with us whether their limited partners may take the position that their distributive share of income is not subject to the 3.8 percent Medicare portion of self-employment tax.
Please contact your Schulte Roth & Zabel LLP tax attorney for any questions about the potential consequences of the Tax Court opinion.
Philippe Benedict – New York (+1 212.756.2124, philippe.benedict@srz.com)
David S. Griffel – New York (+1 212.756.2428, david.griffel@srz.com)
Andrea (Andi) Mandell – New York (+1 212.756.2174, andi.mandell@srz.com)
Joseph Reich – New York (+1 212.756.2026, joseph.reich@srz.com)
Shlomo C. Twerski – New York (+1 212.756.2510, shlomo.twerski@srz.com)
Alan S. Waldenberg – New York +1 212.756.2501, alan.waldenberg@srz.com)
David S. Wermuth – New York (+1 212.756.2777, david.wermuth@srz.com)
Elie Zolty – New York (+1 212.756.2052, elie.zolty@srz.com)
[1] Soroban Capital Partners LP v. Commissioner, 161 T.C. No. 12 (2023).
[2] Renkemeyer, Campbell & Weaver, LLP v. Commissioner, 136 T.C. No. 7 (2011), a case that involved a partnership that did not have limited partners under the applicable state law.
[3] All section references are to the US Internal Revenue Code of 1986, as amended.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. © 2023 Schulte Roth & Zabel LLP. All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

Funding Employer-Sponsored Group Health Coverage: The Group Captive Solution
ARTICLE / REPORT
Funding Employer-Sponsored Group Health Coverage: The Group Captive Solution
November 2023
Read time: 2 min
The enactment of the Affordable Care Act in 2010 led to a sharp increase in employers self-funding their group health insurance plans, with the market tripling in size in the decade that followed. While larger employers can self-fund their group medical coverage in a relatively efficient manner, it does not work well for smaller employers. As year-over-year spending on healthcare in the United States outpaces growth in real gross domestic product by wide margins, employers of all sizes continue to seek to make group health insurance coverage available to their employees at a reasonable cost. Group captive-funded medical stop-loss insurance offers a way for smaller employers to obtain the full benefit of self-funding. This Special Report explains what group medical stop-loss captives are and how they are structured and regulated.

New From January 2024 | Participation Exemption for European Corporations on Disposal of Shareholdings
ARTICLE / CLIENT ALERT
New From January 2024 | Participation Exemption for European Corporations on Disposal of Shareholdings
November 28, 2023
Read time: 9 min
The Italian government recently approved a draft 2024 budget law which provides for the extension of the domestic participation exemption regime on disposal of shareholdings (PEX) to those non-resident corporations that: (i) are resident in the European Union (EU) or resident in the European Economic Area (EEA) and allowing an adequate exchange of information, (ii) do not have a permanent establishment (PE) in Italy and (iii) are subject to corporate income tax in their State of residence (in practical terms, all EU Member States plus Iceland, Norway and Liechtenstein).
New Tax Rules on Gains Deriving from “Qualifying” Shareholdings
Article 68 of the Italian Income Tax Code (IITC), governing the taxable base of capital gains qualifying as “other income”, will be amended to reduce to 5% the taxable base of capital gains deriving from the disposal of “qualifying shareholdings”1 if all the subjective and objective requirements for the PEX regime are met (article 87, IITC)2.
According to the new rule, qualifying capital gains made by non-resident companies would be subject to a 1.3% effective tax burden, resulting from the application of the 26% substitute tax on a taxable income equal to 5% of the capital gain, substantially reducing the tax burden, as compared to the current 26% tax rate (substitute tax).
Non-qualifying shareholdings are not affected as they are already tax-exempt for EU/EEA corporations under existing Italian law. The new law also states that if the capital losses exceed the capital gains, the excess is deducted up to 5% of their amount from the taxable capital gains arising in the following four financial years.
The Supreme Court’s “French Cases” Behind the Reform
The new provision is intended to align national law to the Supreme Court’s judgments no. 21261 issued on July 19, 2023 and no. 27267 issued on September 25, 2023, which ruled that non-resident companies without an Italian PE are entitled to apply the same national regime enjoyed by Italian-resident corporations on the capital gain made upon sale of a participation (provided that the objective and subjective requirements for the PEX regime are met), thus resulting in the 1.2% tax burden applicable to resident companies (i.e., 24% corporate income tax (CIT) on a taxable income equal to 5% of the capital gain).
The motivation for the change in national law comes from the aforementioned Supreme Court position that not applying the PEX regime to non-resident companies without an Italian PE would infringe the fundamental freedoms established under the Treaty on Functioning of the European Union (TFEU). Based on this reasoning, the Supreme Court upheld the position of a French parent company holding a “substantial participation” in an Italian subsidiary (i.e., a participation entitling to 25% or more of the profits of the subsidiary under the Protocol to the treaty). In this case, pursuant to Art. 8, let. b) of the Protocol attached to the Italy-France Double Tax Convention (DTC), Italy is not prevented from taxing any such capital gain under the treaty, with the result that the French corporation would have been fully taxed on the gain, whereas its Italian-resident equivalent corporation would have enjoyed a 1.2% effective tax rate.
The Impact of the New Provision
This legislative amendment is welcome in that it is intended to align national law to EU fundamental freedoms, taking also into account past experience in respect to dividends distributed by Italian subsidiaries to EU and white-listed EEA resident parent companies, which are subject to a 1.2% withholding tax, the same tax burden which applies to an Italian-resident corporation)3.
However, while the tax burden was perfectly aligned with the change in the regime of dividends, the new measure on capital gains leaves (probably inadvertently) a small difference in the regime applicable to resident companies. Qualifying capital gains will be taxable at a 1.3% effective rate to non-resident corporations versus a 1.2% effective rate applicable to resident corporations. This small gap derives from the change in law introduced by Law 27 December 2017 no. 205 which subjected qualified capital gains to the 26% substitute tax. Before this change, capital gains made by non-resident companies were subject to the 24% CIT. A full alignment to the regime of resident corporations would have required not only the exemption of 95% of the tax base but also the adoption of the same tax rate (24%).
On the basis of the DTCs currently in force with EU and EEA members, the amendment of article 68 IITC would mainly affect French and Liechtenstein companies4: France is affected because the provision of the Protocol attached to the Italy-France DTC, as mentioned, allows Italy to tax substantial capital gains made by French companies. Liechtenstein is affected because there is currently no DTC in force (the July 12, 2023 DTC is not yet enacted). However, Liechtenstein has entered a Tax Information Exchange Agreement (TIEA) with Italy (ratified on November 3, 2016) which brings Liechtenstein within the scope of the new provision.
The new provision might also have a marginal impact on those EU and EEA members which have a DTC with Italy allowing the source country to tax capital gains on shares of “real estate companies”. This is currently the case for Finland, Romania, Estonia, Latvia and Lithuania, and will be the case for Liechtenstein when the new DTC is enacted. The number of affected jurisdictions is expected to increase when Italy ratifies the Multilateral Convention (MLI) to Implement Tax Treaty Related Measures to Prevent Base Erosion and Profit Shifting (BEPS). In fact, Italy, by approving article 9§4 of the MLI, elected to adopt the provision of art. 13§4 of the post-BEPS OECD Model Convention5, which would grant an automatic extension to those jurisdictions which adopted the same MLI option. According to treaty provisions in line with article 13§4, Italy will be entitled to tax gains on participations in Italian or non-resident companies whose value derives more than 50% from real estate property situated in Italy, irrespective of the “passive” or “active” function of such immovable property. The national provisions also allow to tax such gains. However, absent the new provision which amends article 68 IITC, a non-resident company would be taxed at 26% on a gain on the alienation of a qualifying shareholding in a resident company whose value derives more than 50% from real estate property situated in Italy, even if such immovable property has an “active” function (i.e., it is immovable property used directly in the operation of the enterprise, or for the production or exchange of which the business activity is actually directed), while a similar gain realized by a resident company would qualify for the 95% PEX regime. Now, the new provision would extend the 95% PEX to such gains made by non-resident companies for which the DTC allows Italy to tax6.
Are Italian Provisions in Breach of EU Law?
Apart from the aforementioned slight difference in the effective tax rate (1.3% vs. 1.2%) other aspects seem likely to frustrate the new rule’s objective of bringing national legislation in line with EU fundamental freedoms.
It should be noted that the Supreme Court’s position which triggered the legal change makes reference to the well-established case law of the Court of Justice of the European Union (CJEU) on discrimination and restrictions. However, while the Supreme Court’s judgment no. 21261 makes a generic reference to EU fundamental freedoms, the most recent CJEU jurisprudence indicates that any rule designed in the way in which the PEX has been designed should be tested against the provisions of the free movement of capital, rather than those on the freedom of establishment, which applies also to non-EU Countries7. It should be noted that this principle seems to be further supported by the afore mentioned September 25, 2023 judgement no. 27267, which also makes reference to the free movement of capital, albeit in a not entirely clear manner.
The new draft rule, however, is not inclusive of the non-EU/EEA corporations resident in States allowing an adequate exchange of information (as enumerated in Decree 4 September 1996), thus leaving the national legislative framework still in potential breach of EU fundamental freedoms (i.e., free movement of capital). Indeed, based on the Supreme Court’s decision, it could be argued that the PEX regime should also be extended to “white-listed” non-EU parent companies holding a qualifying participation in an Italian company and making a capital gain taxable in Italy based either on the applicable DTC rules, or on the absence of a DTC with Italy.
Should the PEX regime be extended to non-EU/EEA corporations it would therefore impact on gains made by corporations:
- Resident in a state having a DTC which allows Italy to tax any such gains irrespective of the activity carried out by the Italian company. This would be the case for instance for China, South Korea, Brazil and Israel
- Resident in a state having a DTC which allows Italy to tax gains on disposals of shareholdings in real estate companies. In respect of these jurisdictions the extension of PEX may impact shareholdings in “active” real estate companies as defined above. This would be the case for several jurisdictions such as, for example, the United States, Saudi Arabia, Hong Kong, Colombia, Jamaica, Panama and Uruguay
- Resident in a state not having a DTC with Italy, but that has entered into a TIEA with Italy. In any such case, the PEX regime would extend to an even larger number of jurisdictions such as, for example, Andorra, Bermuda, the Cayman Islands, Guernsey, Gibraltar, the Isle of Man, Jersey and Monaco.
Entry into Force
With regard to the effective date of the draft bill, it is expected that capital gains would be affected by the new provision if realized on or after January 1, 2024. For previous financial years a refund claim to be filed with Italian Tax Authorities should be considered. This would likely result in a tax controversy, similar to what happened in the Supreme Court French cases, mentioned above.
